Clinical Trial Update: Study of NU172 as Anticoagulation in Patients Undergoing Off-pump CABG Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating NU172 as an anticoagulant in patients undergoing off-pump coronary artery bypass grafting; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• NU172

Snippet

Sponsor: ARCA Biopharma, Inc. | Conditions: Heart Disease | Phase 2 | Status: UNKNOWN